Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies ; volume:26 ; number:1 ; day:3 ; month:4 ; year:2024 ; pages:1-6 ; date:12.2024
Arthritis Research & Therapy ; 26, Heft 1 (3.4.2024), 1-6, 12.2024
- Creator
-
Campochiaro, Corrado
Farina, Nicola
De Luca, Giacomo
Batani, Veronica
Trignani, Giorgia
Vignale, Davide
Palmisano, Anna
Matucci-Cerinic, Marco
Dagna, Lorenzo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-024-03310-z
- URN
-
urn:nbn:de:101:1-2406190924236.821514348574
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Campochiaro, Corrado
- Farina, Nicola
- De Luca, Giacomo
- Batani, Veronica
- Trignani, Giorgia
- Vignale, Davide
- Palmisano, Anna
- Matucci-Cerinic, Marco
- Dagna, Lorenzo
- SpringerLink (Online service)
Other Objects (12)
Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series
Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
Resistin in idiopathic inflammatory myopathies
Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial
The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
Cardiovascular manifestations in idiopathic inflammatory myopathies
Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome
Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series
Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
Resistin in idiopathic inflammatory myopathies
Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial
The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
Cardiovascular manifestations in idiopathic inflammatory myopathies
Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome
Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series
Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
Resistin in idiopathic inflammatory myopathies
Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial
The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
Cardiovascular manifestations in idiopathic inflammatory myopathies